The objective of this study was to determine the mortality rate and the functional outcomes of stroke patients admitted to the intensive care unit (ICU) and to identify predictors of poor outcome in this population.
Cerebrovascular accident remains a major source of morbidity and mortality in Australia 1,2 and worldwide 3 . Survivors of first-ever stroke have a higher mortality rate and reduced functional outcome compared to the general population of the same age and gender [4] [5] [6] . About 10% of stroke patients are admitted to the Intensive Care Unit (ICU) 7 . The common reasons for admission to the ICU include deteriorating states of consciousness, failure to protect the airway and impending aspiration pneumonia, although more recently the indications for admission have expanded to include post thrombolysis and surgery. Whilst some data point to the benefits of ICU admission for these patients 8 , more recent studies indicate that mechanical ventilation of stroke patients is associated with poor prognosis (high in-hospital and one-year mortality and poor functional outcome) [9] [10] [11] . This has reignited the debate about the role of intensive care in the management of these patients and generated a sense of therapeutic nihilism towards those patients requiring aggressive ventilatory support. The question of whether ICU admission of stroke patients is beneficial is therefore a pertinent one, given the escalating costs of providing intensive care in a climate of budgetary constraints. The few studies examining these issues emanate from North American hospitals and may not reflect Australian experience. Furthermore there are little data available on the functional outcome of survivors 12 amongst those who required ICU.
We therefore conducted a retrospective study of all patients with stroke referred to our ICU between 1994 and 1999. Our main objectives were to identify the mortality rate, functional outcomes of survivors and predictors of poor outcome in patients admitted to the intensive care unit with a primary diagnosis of stroke.
MATERIALS AND METHODS
We obtained permission from the Ethics Committee of the Royal Brisbane Hospital to perform the audit. From the ICU database we reviewed the records of all patients admitted to the ICU of Royal Brisbane Hospital with the primary diagnosis of stroke between January 1994 and December 1999. From the Hospital Medical Records Department, using International Classification of Disease ICD-9 and ICD-10, we obtained the total number of patients admitted to the hospital during the same period with a primary diagnosis of stroke. Stroke was defined as the sudden onset of a focal neurological deficit. Those with primary subarachnoid haemorrhage were excluded from the analysis. The decision to admit stroke patients to the ICU was made by the intensivist following consultation with referring physician.
All patients in the ICU had ECG and arterial pressure monitoring as part of standard clinical practice. When patients required sedation for intensive care procedures, facilitation of positive pressure ventilation or transport, propofol (1-3 mg/kg/hour) in combination with alfentanil (10-20 µg/kg/h) or midazolam (0.1-0.2 mg/kg/h) in combination with fentanyl (1-2 µg/kg/h) were used. Endotracheal intubation was performed and positive pressure ventilation initiated when clinically indicated.
Medical treatment included blood pressure control, normothermia, and normoglycaemia. None of these patients received thrombolysis or underwent hemicraniectomy as part of the stroke management.
Data Collection
Clinical and biological variables collected included gender, age, type of stroke (ischaemic or haemorrhagic), site of stroke (anterior or posterior circulation), pupillary responses and Glasgow Coma Scores. Where possible, information on the latter two variables were collected during the pre-hospital ambulance phase, in the department of emergency medicine (DEM) and during intensive care assessments.
Medical history was reviewed for the following risk factors: pre-existing atrial fibrillation, hypertension, renal failure, diabetes mellitus, obesity and lipid abnormalities. The following co-morbidity factors were also collected: previous myocardial infarction, previous stroke, previous head injury, anticoagulation, and history of seizures.
Outcome Assessment
Mortality and functional outcome were used as end-points. We assessed patient mortality at three different time points: ICU, in hospital and at three months. Functional outcome was assessed using the Barthel Score (assessments by the occupational therapists), the Rankin Sscore and statements about independent lifestyles following discharge 13, 14 .
Statistical Analysis
Univariate analysis for continuous variables used t-tests and Kruscall Wallis tests where appropriate. Univariate analysis for categorical variables used Chisquared or Fisher's Exact test where appropriate. Statistical significance was taken at P<0.05. Logistic regression modelling was used to identify clinical mortality predictors. Stata (Stata Corporation, College Station, Texas, U.S.A.) was used for the analysis.
RESULTS
In the six-year period between 1994 and 1999, 2978 patients had been admitted to the Royal Brisbane Hospital with a diagnosis of stroke. Of these, 557 patients died, giving rise to an overall mortality of 19%. During the same period, 61 patients were admitted to the ICU with a diagnosis of either haemorrhagic or ischaemic stroke. Three of the patients' files were not found, or had missing data, 629 OUTCOME OF STROKE PATIENTS ADMITTED TO There were no significant differences in the prevalence of premorbid risk factors between those who survived and those who died ( Table 2) .
Factors predictive of ICU mortality are shown in Table 3 .
Haemorrhagic stroke compared to ischaemic stroke (P=0.02) and fixed pupil(s) on presentation were significant predictors of ICU mortality (P<0.001). The anatomical location of stroke and the GCS on arrival to hospital were not predictors of death in ICU.
The hospital mortality was 46.6% (Table 4 ). Haemorrhagic stroke (P<0.05), median GCS on hospital admission (10 vs 7, P<0.01) and on ICU discharge (14 vs 6, P<0.001) and pupillary reactivity (P<0.001)were strong predictors of hospital survival.
Functional Status
All the survivors were assessed at three months. The mean Barthel and Rankin Scores in the survivors were 63.75±32 and 2.65±1.8 respectively. Only 46% of those who were alive at three months were functionally independent. The mean Barthel score was significantly different between the independent and dependent survivors (94±6 vs 45±26, P<0.001). A substantial number of patients with good functional outcomes had lower Rankin Scores (92% vs 11%, P<0.001). No patient with a GCS of less than 6 was a functional survivor.
Using multiple regression analysis, predictive variables were not linear in the logit and could not be modelled well with polynomial transformation. Due to sample size limitations and the need for multiple levels of categorical variables, the reporting of univariate analysis only was appropriate.
DISCUSSION
The main message from our study is that a majority of patients with stroke requiring admission to ICU have a high in-hospital and three-month mortality. A large proportion of patients surviving to hospital discharge remain functionally dependent at three months. Whilst accurate prediction of survival and functional outcome is not possible from our study, haemorrhagic stroke, fixed dilated pupil(s), and GCS less than 10 during assessment was associated with increased mortality and poor functional outcome. 
Predictors of Prognosis Glasgow Coma Score
The GCS has clearly been shown to correlate with outcome in patients with head injury and in patients suffering out-of-hospital cardiac arrest 15 . In a recent study by Steiner et al, the GCS has also been shown to correlate with hospital mortality in stroke patients requiring mechanical ventilation 8 . The results from our study also testify to the prognostic value of GCS in predicting outcome.
Pupillary Reactivity as a Prognostic Predictor
Patients who presented with at least one fixed dilated pupil appeared to have poor clinical outcomes. This observation is in concordance with that of Steiner et al 8 and Santoli et al 11 who noted that absence of pupillary reactivity had a high positive predictive value for death. Importantly, whilst there were three patients in the ICU survivors group with at least one non-reactive pupil, these patients all died in hospital.
Both GCS and pupillary reactivity are clinical surrogates for intracranial pressure. The degree of normality of both these responses has an inverse relationship to the extent of intracranial hypertension. This may explain their ability to prognosticate outcome reliably.
Presence of Co-morbidities
In our study the presence of other co-morbidities bore no statistical relationship to outcome. This may well be due to the small sample size of our study. With this sample size, a proportional difference in comorbidities between 0.23-0.29 was required for an alpha of 0.05 and a power of 0.8. Our study was too small to detect clinically significant difference in the proportions of co-morbities. The power to detect a difference in our study was between 0.05 and 0.2.
Functional Outcome in Survivors
Of the survivors at three months, 46.4% were successfully living an independent lifestyle in our study. This compares with the results of Grotta et al 16 in which only 20% of those intubated and admitted to ICU had an independent lifestyle. They also found that GCS correlated with the likelihood of a good functional outcome. No patient with a GCS less than 6 was a functional survivor.
Comparison with Previously Published Data
The results from four published studies examining ICU mortality of stroke patients are presented in Table 5 .
The data from our study are in concordance with that of Steiner et al 8 and Berrouschott et al 10 . Whilst differences in patient selection and sample sizes may explain small variations in the results, the overriding message from most studies is that there was a high mortality rate in those with stroke admitted to ICU. Furthermore, even amongst those who survive, a substantial proportion did not achieve significant functional recovery.
Limitation of the Above Study
The main limitation of the study is its retrospective nature and the small number of patients with stroke presently admitted to the ICU. Consequently, the criteria for admission of these patients into the ICU was not defined prospectively, but was based on the decision made by the intensivist following consultation with the referring physician. This introduces a selection bias. Although patients were treated according to "best practice guidelines", ICU management was not standardized and there was no control group. Furthermore, the audit was carried out over a five-year period between 1994 and 1999. Newer therapeutic options and management strategies have since emerged. However, these have not become commonplace. Nevertheless, the use of end-points such as mortality and functional quality of life should militate against some of the above limitations.
Is There a Role for ICU in Patients with Stroke?
The findings that stroke patients requiring intensive care have a high mortality and reduced quality of life questions the role of the ICU for these patients. Based on the data from our preliminary study, we do 631 OUTCOME OF STROKE PATIENTS ADMITTED TO not advocate a blanket refusal policy as it would be clearly inappropriate and will become a self fulfilling prophecy. The real question is identifying which stroke patient will benefit from support in the ICU. Although our study could not identify favourable prognostic indices, a few clinical situations may merit admission to the ICU. Stroke in a young individual and control of hypertension in acute stroke may warrant ICU admission. Recently, a number of advances in the management of stroke have been made which include thrombolysis, hemicraniectomies and neuronal protection. Whilst there are no data to show that ICU support in these situations improves patient outcome, clearly mechanical ventilation and ICU support will remain an integral component within these new therapeutic approaches until their role in the management becomes clearly defined. Finally, the ICU has a role in the management of patients who might develop brain death and become potential organ donors on the one hand, or those who require terminal palliative care.
In conclusion, in this preliminary retrospective study we have identified that GCS and pupil reactivity are prognostic indicators for survival and functional outcomes in stroke patients requiring admission to intensive care. Intensive care admission was associated with a high mortality rate and a high likelihood of dependent lifestyle after hospital discharge. We suggest that clinicians critically examine the suitability of patients requiring ICU admission in the light of these findings and other published data. Nevertheless, the problem remains that there are some patients with low coma scores and good outcomes, and nihilism is not always justified. However, a means of identifying these patients is required. We would support a large prospective trial to determine other predictors to help answer which stroke patients should be admitted to intensive care.
